https://www.pharmanow.live/latest-news/biological-e-appoints-v-krishnakumar-ceo-biopharma-cdmo 2026-10-03T13:43:23+05:30 Pharma Now en 2026-10-03T00:00:00+05:30 Biological E Appoints V Krishnakumar CEO Of Global Biopharma CDMO Biological E https://pharmanow.nyc3.cdn.digitaloceanspaces.com/p/agents-data/images/news/6ac409e4-9c3f-43f0-8630-9d4a57ff0cdb/768e568c-f325-4ab4-83c1-4016f8df73cc.png https://www.pharmanow.live/latest-news/zydus-lifesciences-extends-sunshine-healthcare-lanka-jv-deadline-december-2026 2026-10-03T13:44:22+05:30 Pharma Now en 2026-10-03T00:00:00+05:30 Zydus Extends Sunshine Healthcare JV Timeline To December 2026 Zydus https://pharmanow.nyc3.cdn.digitaloceanspaces.com/p/agents-data/images/news/6ac409e4-9c3f-43f0-8630-9d4a57ff0cdb/9fa0e768-4ca7-4c8d-a69d-599c169c0178.png https://www.pharmanow.live/latest-news/godavari-biorefineries-secures-mexican-patent-antiviral-compounds 2026-10-03T13:46:49+05:30 Pharma Now en 2026-10-03T00:00:00+05:30 Godavari Biorefineries Secures Mexican Antiviral Patent Godavari https://pharmanow.nyc3.cdn.digitaloceanspaces.com/p/agents-data/images/news/6ac409e4-9c3f-43f0-8630-9d4a57ff0cdb/538cf8f1-9dac-4602-899d-33deee0307d0.png https://www.pharmanow.live/latest-news/bayer-2-2-billion-us-manufacturing-site-reshoring 2026-10-03T14:20:33+05:30 Pharma Now en 2026-10-03T00:00:00+05:30 Bayer Commits $2.2 Billion To New U.S. Sites Amid Reshoring Drive Bayer https://pharmanow.nyc3.cdn.digitaloceanspaces.com/p/uploads/news/original/bayer-2-2-billion-us-manufacturing-site-reshoring-202620261003142026.webp https://www.pharmanow.live/latest-news/novo-nordisk-denecimig-bla-review-extended-fda-facility-remediation 2026-10-03T14:12:22+05:30 Pharma Now en 2026-10-03T00:00:00+05:30 FDA Plant Inspection Delays Novo Nordisk Denecimig BLA Review Now FDA https://pharmanow.nyc3.cdn.digitaloceanspaces.com/p/uploads/news/original/novo-nordisk-denecimig-bla-review-extended-fda-facility-remediation-202620261003141211.webp https://www.pharmanow.live/latest-news/eli-lilly-fda-approval-pirtobrutinib-first-line-cll-sll 2026-10-03T13:13:19+05:30 Pharma Now en 2026-10-03T00:00:00+05:30 FDA Approves Lilly Pirtobrutinib For First Line CLL SLL Patients FDA https://pharmanow.nyc3.cdn.digitaloceanspaces.com/p/uploads/news/original/eli-lilly-fda-approval-pirtobrutinib-first-line-cll-sll-202620261003131309.webp https://www.pharmanow.live/latest-news/fda-updates-hctp-non-blood-biologics-deviation-reporting-codes-october-2026 2026-10-03T13:09:39+05:30 Pharma Now en 2026-10-03T00:00:00+05:30 FDA Updates Deviation Codes For Biologics Effective October 2026 FDA https://pharmanow.nyc3.cdn.digitaloceanspaces.com/p/uploads/news/original/fda-hctp-non-blood-biologics-deviation-reporting-codes-october-202620261003130936.webp https://www.pharmanow.live/latest-news/fda-updates-biological-product-deviation-reporting-blood-product-codes-october-2026 2026-10-03T13:04:58+05:30 Pharma Now en 2026-10-03T00:00:00+05:30 FDA Updates Blood Product Deviation Codes Effective October 2026 FDA https://pharmanow.nyc3.cdn.digitaloceanspaces.com/p/uploads/news/original/fda-biological-product-deviation-reporting-blood-product-codes-october-202620261003130446.webp https://www.pharmanow.live/latest-news/abbvie-hrsa-340b-rebate-model-pilot-imbruvica-linzess-vraylar-2027 2026-10-03T12:59:38+05:30 Pharma Now en 2026-10-03T00:00:00+05:30 AbbVie Joins HRSA 340B Rebate Pilot For Three Drugs January 2027 AbbVie https://pharmanow.nyc3.cdn.digitaloceanspaces.com/p/uploads/news/original/abbvie-hrsa-340b-rebate-model-pilot-imbruvica-linzess-vraylar-202720261003125925.webp https://www.pharmanow.live/latest-news/fda-transparency-roadmap-complete-response-letters-fy27-priorities 2026-10-03T12:52:37+05:30 Pharma Now en 2026-10-03T00:00:00+05:30 FDA Releases Transparency Roadmap With Complete Response Letters Now FDA https://pharmanow.nyc3.cdn.digitaloceanspaces.com/p/uploads/news/original/fda-transparency-roadmap-complete-response-letters-fy27-priorities-202620261003125137.webp